Clinic culture change aims to boost HIV outcomes for black patients

NCT ID NCT06462807

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a program called ARC that helps HIV clinics improve their work environment and reduce discrimination. Researchers will compare viral suppression and care retention in clinics using ARC versus standard care. The goal is to see if better clinic culture leads to better health outcomes for people living with HIV, especially Black patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ARC (Accessibility, Responsiveness, Continuity) program

What this could lead to

If successful, this could show that improving clinic culture and reducing discrimination helps more people with HIV stay in care and achieve viral suppression.

What could go wrong

This is a small early-stage trial with only 4 clinics, so results may not apply broadly. The intervention is behavioral, not a drug, so effects may be modest.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV/AIDS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••